Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma

NCT00937937 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00937937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00937937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 1, 2009
Completion date
March 19, 2027
Enrollment
72 (actual)
Sites
190

Conditions

As the registry lists them; a condition with its own page is linked.

acral lentiginous melanoma, cutaneous nodular melanoma, lentigo maligna melanoma, low-csd melanoma, mucosal melanoma, recurrent melanoma, stage iv cutaneous melanoma ajcc v6 and v7